semaglutide liver fat reduction CDSCO Clears Wegovy for MASH — India's First GLP-1 Approval for Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on How Semaglutide Treats MASH: The

However, these widely used assays have not been designed to identify HCV subtypes other than 1a and 1b, nor to recognized mixed genotype/subtype infections

Some people with type 1 diabetes are using do-it-yourself, user-driven, open-source artificial insulin delivery systems, which use commercially available CGM systems and pumps, with software algorithms that communicate with both and can reverse-engineer the pump control of basal and corrective doses [93]

Biophysics 79 (2), 337347

That foundation is the 40:1 myo-inositol to D-chiro-inositol ratio, which has direct PCOS RCT evidence behind it for ovulatory function and insulin sensitivity (Nordio & Proietti 2012

Br J Clin Pharmacol 78(3):441453